Xiaofan Zhu
University of Science and Technology of China(CN)Chongqing University(CN)Anhui Medical University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)University of Michigan–Ann Arbor(US)Institute for Stem Cell Biology and Regenerative Medicine(IN)Tianjin Municipal Engineering Design and Research Institute(CN)Tianjin Anding Hospital(CN)Tianjin People's Hospital(CN)Institute of Hematology & Blood Diseases Hospital(CN)First People's Hospital of Chongqing(CN)Tianjin Medical University(CN)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Hematopoietic Stem Cell Transplantation, Childhood Cancer Survivors' Quality of Life, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase(2014)2,397 cited
- → Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia(2019)293 cited
- → Identification of functional cooperative mutations of SETD2 in human acute leukemia(2014)247 cited
- → Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia(2020)234 cited
- → Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia(2021)151 cited
- → Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG‐ALL 2008: The first nation‐wide prospective multicenter study in China(2018)144 cited